Cosponsor the Medicare Multi-Cancer Early Detection Screening Coverage Act, HR 1946/S. 1873
Early screening for cancer is important because when detected at later stages, treatments are more limited, and outcomes are generally poorer. Newer, innovative multi-cancer screening technology has the potential to detect more cancers at earlier stages. Several private and academic entities are currently developing multi-cancer early detection blood-based tests. Published data indicate that some of these tests can screen for many cancers at the same time, including some rare cancers.